, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
million or 7%, mainly due to an increase in cost of real estate sold which varied with an increase in revenue from sales of real estate. Page 3 of 4 IV Expense (Unit: Million Baht) Second quarter 6-month
) Expense Quarter 2/2020 company and its subsidiaries has total expenses of 607.05 Million Baht as 227.63 Million Baht decreased from same period of year 2019 which has total expenses of 834.68 Million Baht
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
the new iPhone13 in the previous quarter. However, the sales margin grew from +0.9% in 4Q21 to +1.4% in 1Q22 due to an increased sales mix of higher-margin handsets. Cost & Expense In 1Q22, the cost of
: Electricity revenue and cost of sale were decreased caused by the lower electricity generation due to a scheduled maintenance in Q3/2020. Meanwhile, corporate income tax expense was decreased because the tax
revenue 19,990 18,308 18,138 (9%) (1%) 29,057 36,446 25% Cost of sales (excluding depreciation and amortization)1 (14,062) (12,943) (12,488) (11%) (4%) (20,651) (25,432) 24% Gross profit1 5,928 5,365 5,650
of 2.08 percent and increase in raw material cost, salary and benefits of the employees, electricity expenses, gas expense and repair and maintenance expenses. Cost of services was Baht 96.07 million
) 3,068 2,296 772 34% Deferred income (expense) tax 25 (166) 1 2 26 (164) 190 116% Profit (Loss) before FX and impact of lease income 3,071 2,142 23 (10) 3,094 2,132 962 45% Profit (Loss) from FX 522 (90
other expenses were 2,035 million baht, increased by 112 million baht or 6% y-y due to increase of advertising expense 55% y-y. However, the Company still maintained effective operating cost control with